Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Febrile Neutropenia (FN)”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Not applicableUnknownNCT03618810
What this trial is testing

Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer

Who this might be right for
Febrile Neutropenia
Zhejiang Cancer Hospital 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT07187908
What this trial is testing

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

Who this might be right for
Primary/Secondary PreventionHigh Risk for Febrile Neutropenia of Chemotherapy RegimensIntermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia
Henan Cancer Hospital
Not applicableStudy completedNCT07113314
What this trial is testing

Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy

Who this might be right for
Febrile Neutropenia (FN)SepsisChemotherapy Treatment
Fondazione IRCCS Policlinico San Matteo di Pavia 160
Not applicableStudy completedNCT04460079
What this trial is testing

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Who this might be right for
Chemotherapy-induced Neutropenia
Cinnagen 654
Not applicableStudy completedNCT01574235
What this trial is testing

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Who this might be right for
Solid TumorsMalignant HemopathyChemotherapy-induced Febrile Neutropenia (FN)
Hospira, now a wholly owned subsidiary of Pfizer 2,114
Not applicableUnknownNCT05149547
What this trial is testing

MNGS Versus Blood Culture in FN

Who this might be right for
InfectionsHematologic DiseasesFebrile Neutropenia
Peking University People's Hospital 300
Not applicableStudy completedNCT02324231
What this trial is testing

SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia

Who this might be right for
CancerPediatricsFever+2 more
Swiss Pediatric Oncology Group 269
Not applicableStudy completedNCT05689450
What this trial is testing

Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

Who this might be right for
Febrile Neutropenia (FN)
University Hospital, Basel, Switzerland 92
Testing effectiveness (Phase 2)Study completedNCT04477616
What this trial is testing

Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 160
Large-scale testing (Phase 3)Study completedNCT04466137
What this trial is testing

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

Who this might be right for
Non-Myeloid Malignancy
Xiamen Amoytop Biotech Co., Ltd. 398
Not applicableStudy completedNCT02178475
What this trial is testing

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Who this might be right for
Chemotherapy-induced Febrile Neutropenia
Amgen 943
Not applicableStudy completedNCT01683370
What this trial is testing

Pediatric FN Definition 2012 Bern

Who this might be right for
Cancer in Children/AdolescentsFever in Neutropenia
Dr. Roland Ammann 39
Post-approval studies (Phase 4)Not Yet RecruitingNCT06665737
What this trial is testing

Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Granulocyte Colony Stimulating FactorFebrile Neutropenia (FN)+1 more
Department of Medical Services Ministry of Public Health of Thailand 126
Not applicableLooking for participantsNCT07372131
What this trial is testing

Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients

Who this might be right for
Bloodstream InfectionGram Negative InfectionsBacteraemia Caused by Gram-Negative Bacteria+1 more
Humanitas University 172
Large-scale testing (Phase 3)Study completedNCT00784368
What this trial is testing

A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection

Who this might be right for
MycosesCandidiasisAspergillosis+4 more
Janssen Pharmaceutical K.K. 55
Not applicableUnknownNCT04662892
What this trial is testing

An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca

Who this might be right for
Febrile NeutropeniaNon-myeloid Malignancy
Coherus Oncology, Inc. 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06143735
What this trial is testing

Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 99
Large-scale testing (Phase 3)WithdrawnNCT06254742
What this trial is testing

A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies

Who this might be right for
Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk
Jiangsu HengRui Medicine Co., Ltd.
1,076